Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are injectable antihyperglycemic medications known for effective glycemic control in type 2 diabetes mellitus, reducing glucose levels via insulin secretion and glucagon suppression [1]. The gene discussed is GCG; the disease is diabetes mellitus.